In this podcast, Peter Henke, MD, talks about his recent session at the 2021 VEITHsymposium, during which he talked about the research supporting newer direct oral anticoagulation (DOAC) therapies, the future of research, and which patients should receive DOACs after lower extremity bypass surgery.

In this podcast, Peter Henke, MD, talks about his recent session at the 2021 VEITHsymposium, during which he talked about the research supporting newer direct oral anticoagulation (DOAC) therapies, the future of research, and which patients should receive DOACs after lower extremity bypass surgery.

In this podcast, Peter Henke, MD, talks about his recent session at the 2021 VEITHsymposium, during which he talked about the research supporting newer direct&nbsp;oral anticoagulation (DOAC) therapies, the future of research, and which patients should receive DOACs after lower extremity bypass surgery.

Peter Henke, MD, on Optimal Anticoagulation Management After Lower Extremity Bypass Surgery

Podcasts360, powered by Consultant360, features short interviews with medical professionals about current research, news, and general information for health care providers in 35+ specialties.

Share Peter Henke, MD, on Optimal Anticoagulation Management After Lower Extremity Bypass Surgery

Sign up to save your podcasts

Peter Henke, MD, on Optimal Anticoagulation Management After Lower Extremity Bypass Surgery

Peter Henke, MD, on Optimal Anticoagulation Management After Lower Extremity Bypass Surgery

More shows like Podcasts360

The Curbsiders Internal Medicine Podcast